| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |